Table 1:
Donor | Blood Plasma (ml) | Seminal Plasma (ml) | Viral load (GE/ml) | ARV Therapy | CD4 count* | ART yrs* |
---|---|---|---|---|---|---|
1 | 3 | 1.0 | 120,000 | Therapy-naïve | 39 | N/A |
2 | 3 | 1.0 | 34,000 | Therapy-naïve | 295 | N/A |
3 | 3 | 1.0 | 1,318,000 | Therapy-naïve | 6 | N/A |
4 | 3 | 0.6 | 35,000 | Therapy-naïve | 453 | N/A |
5 | 3 | 0.65 | 16,000 | Therapy-naïve | 489 | N/A |
6 | 4 | 1.2 | ND | ABC, 3TC, EFV | 1,037 | > 5 |
7 | 4 | 1.2 | ND | ABC, 3TC, DTG | 545 | > 5 |
8 | 4 | 0.9 | ND | TAF, FTC, DTG | 944 | > 5 |
9 | 3 | 1.0 | ND | ABC, 3TC, EFV | 597 | > 5 |
10 | 3 | 0.4 | ND | ABC, 3TC, EFV | 568 | > 5 |
11 | 3 | 0.6 | ND | ABC, 3TC, DTG | 564 | > 5 |
12 | 3 | 0.6 | 32 | TAF, FTC, DTG | 361 | 1 |
13 | 3 | 0.7 | ND | TAF, FTC, DTG | 915 | > 5 |
14 | 3 | 0.6 | ND | TDF, FTC, EFV | 721 | > 5 |
15 | 3 | 1.0 | ND | TAF, FTC, DRV/rit | 395 | > 5 |
16 | 3 | 1.0 | ND | TAF, FTC, DTG | 416 | 0.17 |
17 | 3 | 1.0 | ND | TDF, FTC, EFV | 1,159 | > 5 |
18 | 3 | 1.0 | ND | ABC, 3TC, DTG | 452 | 0.67 |
GE = genome equivalents; ARV – antiretroviral; CD4 count in cells/mm3; yrs = duration in years; NA = not applicable; ND = below limit of detection; ABC = abacavir; 3TC = lamivudine; EFV = efavirenz, DTG = dolutegravir, TAF = tenofovir alafenamide; FTC = emtrictabine; TDF = tenofovir disoproxil fumarate; DRV/r = ritonavir boosted darunavir